Clinical features, complications and results of investigations are analysed in 50 patients diagnosed by jejunal biopsy as having coeliac disease at the Adult Gastroenterology Unit, Royal Victoria Hospital, Belfast, between 1969 and 1983. Only one patient was entirely asymptomatic, but 22 % had no disturbance of bowel habit, and 50% had not lost weight. There were relatively few physical abnormalities on clinical examination. Screening tests using standard haematological and biochemical methods were positive only in between 8 % and 52 % of patients. More specific tests for malabsorption were positive in between 54 % and 84 % of patients.
INTRODUCTION
Only in the past 30 years has 'idiopathic steatorrhoea' or 'non-tropical sprue' been accepted to be the adult variety of coeliac disease. The gluten-free diet was first used to treat adults with this condition in 1952,1 and it is current practice that this dietary modification is recommended 'for life' to ensure continued clinical remission. It is clearly vital, therefore, that an accurate diagnosis of the disorder is made. Crosby capsule biopsy of the jejunum combined with an assessment of clinical and histological response to gluten withdrawal has become accepted as the essential approach to diagnosis. The clinical features which warrant this procedure and the role of screening blood tests and dynamic studies of absorptive function are not so well defined. We have examined the case records of 50 consecutive patients diagnosed as having coeliac disease in the Adult Gastroenterology Unit, Royal Victoria Hospital, Belfast, between 1969 and 1983. We describe the presenting symptoms and signs of these patients and the results of their initial screening investigations. METHODS A retrospective survey in the Medical Records Department, Royal Victoria Hospital, Belfast, identified 50 patients who were investigated and diagnosed as having coeliac disease in the Gastroenterology Unit of that hospital between 1969 and 1983. Patients were accepted into the study if they had histological evidence of severe partial villous atrophy or subtotal villous atrophy on jejunal biopsy and if a good clinical response to gluten withdrawal had been observed. For each patient, details of presenting symptoms and signs, screening blood tests and malabsorption studies were recorded. Body weight at presentation and at outpatient review after institution of the gluten-free diet was also noted. Complicating illness or associated disease in these patients were documented.
Interpretation of tests for malabsorption
An abnormal faecal fat collection was recorded if a patient excreted more than 5g fat daily over a three-day period while on a 50g fat diet. In the fat breath test, breath radioactivity was measured at five, six and seven hours after administration of an oral dose of 5 pCi C14-labelled glyceryl tripalmitate, and fat malabsorption was diagnosed if the maximum concentration of 14C per millimole CO2 in expired air was less than 20 x 10-14%. The D-xylose test was performed with a 25g dose in eight patients, and impaired xylose absorption was recorded if less than 17 % of the oral dose was collected in a five-hour urine collection; a 5g dose was used in 33 patients and absorption considered to be impaired if less than 23 % of the oral dose was collected in a five-hour urine collection. A glucose tolerance test was reported as showing a flat response due to malabsorption if the maximum blood glucose rise after a 50g oral dose was less than 2.2 mmol/l.
RESU LTS
The age of patients at presentation to hospital for assessment was widely varied. There were 16 men whose ages ranged from 15 to 57 years (median, 30 years) and 34 women whose ages ranged from 13 to 71 years (median, 30 years). Initial body weight recordings for the men ranged between 48 and 85 kg, while the women at presentation weiahed between 26 and 61 kg. A value for body weiqht was recorded at outpatient review between four and 12 months after commencement of the gluten-free diet in 45 of the patients. The men showed a mean weight gain of 7.2 kg and the women a gain of 6.6 kg. Symptoms and clinical signs in all 50 patients at initial presentation are summarised in Tables I and 11 Screening blood tests frequently raise the suspicion of malabsorption. A low blood haemoglobin level was found in only 42 % of our patients, which illustrates the danger in relying on such tests to exclude the presence of malabsorption. Cooke and Holmes4 also detected a haemoglobin level of <12 g/dl in 42 % of 170 coeliac patients in England, although an Australian survey described anaemia in 70% of patients.5 A macrocytic blood picture was detected in only 14 % of our study group. Folate deficiency is the commonest cause and a serum folate level of < 2.0 pg/l was found in 38 % of patients. The absence of macrocytosis in some of these individuals was probably related to coexistent iron deficiency. Hallert and colleagues6 noted low serum folate levels in 85% of coeliac patients and found a high yield of coeliac disease when patients with unexplained low folate levels were subjected to jejunal biopsy. Vitamin B12 deficiency is a less frequent abnormality as this is normally absorbed in the terminal ileum which usually remains free of mucosal damage. Of our patients 18% had a low serum B12 level, but in some of these individuals fast small bowel transit rather than terminal ileal damage may have produced impaired absorption of this vitamin. Only 18 % of our patients had a microcytic blood picture but this finding was more common in males. The explanation for the difference between males and females is not clear. Iron deficiency was suggested by a low serum iron in over 40%, and by a high total iron binding capacity in 32% of the group. Associated folate or B12 deficiency may have prevented the development of microcytosis in some of these individuals. With regard to the blood biochemistry tests, hypoalbuminaemia reflects impaired protein synthesis and, in some cases, protein loss into the gastro-intestinal tract. Early reports described this finding in over 50 % of patients with coeliac disease,2 7 although a recent survey had detected serum albumin levels of < 40 g/l in 28 % and <30 g/l in only 4% of patients. 4 Our findings are fairly similar, 27 % of patients having a serum albumin <35 g/l and 10% a level <30 g/l. Hypocalcaemia might simply reflect the low serum albumin concentration, but 52 % of our patients had low serum calcium levels -a higher percentage than had hypoalbuminaemia. When the serum calcium level was corrected for the serum albumin level only 3 Ireland. It appears that milder forms of the disease are being recognised than was the case in the 1950s when the condition was first defined. The presence of severe villous atrophy is rarely seen in conditions other than coeliac disease in adult patients, although this is not the case with children. In clinical practice a more difficult group to classify are those adult patients whose jejunal biopsies show only mild or moderate villous atrophy, findings which can be caused by many disorders. Some of these individuals were encountered in our survey, and although they had been treated by gluten withdrawal, they were not included in this analysis. Similarly, there were two or three individuals who were treated by gluten withdrawal, but for whom no histological confirmation of the diagnosis of coeliac disease was made because of technical failure of the Crosby capsule biopsy instrument. A repeat jejunal biopsy after gluten withdrawal followed by a period of gluten challenge and further biopsy would be of particular value in the assessment of these groups of patients whose diagnosis is less well established, before lifelong gluten avoidance is imposed. A wide spectrum of haematological and biochemical disturbances may occur in coeliac patients but no single test offers a reliable method of screening for the condition. Tests of absorptive function have failed to identify sufficient patients to serve as reliable screening tests for coeliac disease. Better screening tests are required so that milder forms of the condition may be identified. Serum antigliadin antibody determination'6 and release of N-terminal glucagon'7 have been proposed as possible screening tests but further assessment of their sensitivity in adult patients is required. The former reflects the immunological response to gliadin, which is thought to be the toxic component of gluten, and abnormal levels have been found in about 90% of coeliac patients. 16 Release of N -terminal glucagon probably reflects increased stimulation of the distal ileum by food which is malabsorbed in the jejunum.'7 Thus, elevated plasma levels of this hormone are not specific to coeliac disease and are encountered in a variety of conditions associated with small bowel malabsorption. Jejunal biopsy with a Crosby capsule remains the definitive investigation to identify patients with coeliac disease. This procedure can be performed rapidly and without significant discomfort during upper endoscopic examination,'8 and should be undertaken when the diagnosis of coeliac disease is considered.
We are indebted to our predecessors in the Gastroenterology Unit, Royal Victoria Hospital, whose careful documentation of their coeliac patients made our survey possible.
